The global gynecology drugs market is projected to witness consistent growth through the forecast period, driven by rising prevalence of gynecological disorders, increasing awareness of women’s health issues, and expanding access to advanced treatments. The market is expected to reach US$ 82.43 billion by 2031, registering a CAGR of 4.2% during 2025–2031 as healthcare providers...